Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could this drug help spot early signs of psychosis? new study investigates

NCT ID NCT07226895

First seen Nov 12, 2025 · Last updated May 20, 2026 · Updated 24 times

Summary

This study looks at whether a new drug called MT1988 can cause changes in thinking, symptoms, and other measures in people aged 17 to 30 who are at high risk for psychosis. Participants take the drug or a placebo twice daily for 8 weeks and complete regular tests. The goal is not to treat the condition directly, but to find better ways to measure treatment effects in future studies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLINICAL HIGH RISK FOR PSYCHOSIS (CHR) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beth Israel Deaconess Medical Center

    NOT_YET_RECRUITING

    Boston, Massachusetts, 02115, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Columbia University

    RECRUITING

    New York, New York, 10032, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Icahan School of Medicine at Mount Sinai

    RECRUITING

    New York, New York, 10128, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Northwell Health

    RECRUITING

    Glen Oaks, New York, 11004, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Ohio State University

    RECRUITING

    Columbus, Ohio, 43210, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Prevention Science Institute

    RECRUITING

    Eugene, Oregon, 97403, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Temple University

    RECRUITING

    Philadelphia, Pennsylvania, 19122, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of California

    NOT_YET_RECRUITING

    Los Angeles, California, 90095, United States

    Contact Phone: •••-•••-••••

  • University of California, Irvine

    NOT_YET_RECRUITING

    Irvine, California, 92697, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94107, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of North Carolina at Chapel Hill

    RECRUITING

    Chapel Hill, North Carolina, 27514, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Pennsylvania

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Pittsburgh School of Medicine

    RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Washington University

    RECRUITING

    St Louis, Missouri, 63110, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Yale University Conneticut Mental Health Center

    RECRUITING

    New Haven, Connecticut, 06519, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.